Vivli is delighted to announce the publication of a new collection in Wellcome Open Research showcasing the finalists and winners of the 2023 Vivli AMR ... > MORE
Vivli CEO, Rebecca Li and Antimicrobial Development Consultant Patricia Bradford, will speak at the GARDP REVIVE webinar entitled “The value of surveillance data in defining ... > MORE
Vivli is launching the 2024 Vivli AMR Surveillance Data Challenge, funded by GARDP, Paratek, Pfizer and Vivli, on 17th June. The data challenge aims to ... > MORE
We are pleased to announce the publication of a new article in Wellcome Open Research detailing the impactful use of data from the Vivli AMR ... > MORE
We’re thrilled to honor the recipients of the 2023 Vivli Antimicrobial Resistance Surveillance Open Data Re-Use Data Challenge, generously sponsored by Wellcome. At a special ... > MORE
Vivli proudly announces recipients of the 2023 Vivli Antimicrobial Resistance (AMR) Surveillance Open Data Re-Use Data Challenge, sponsored by Wellcome, will be presenting at the ... > MORE
Catch up on an exciting new video now available here showcasing the Challenge winners, several of whom will be presenting their solutions in person at ... > MORE
We are delighted to share with you the AMR Register’s 2023 Progress Report, which highlights our milestones to date and plans for the year ahead. We ... > MORE
Awardees Announced for the Vivli AMR Surveillance Open Data Re-Use Data Challenge, funded by Wellcome Vivli is pleased to announce the awardees of the Vivli ... > MORE
Vivli is launching the Vivli AMR Surveillance Open Data Re-use Challenge, funded by Wellcome, on 19th April 2023. The data challenge aims to stimulate and ... > MORE
Vivli Executive Director, Rebecca Li, spoke at the Duke-Margolis Center for Health Policy event entitled “Data Capture to Measure, Track, and Improve Antibiotic Use” on ... > MORE
Vivli Executive Director Rebecca Li and Antimicrobial Development Consultant Patricia Bradford recently authored a Viewpoint article entitled “Access to industry antimicrobial resistance (AMR) susceptibility surveillance ... > MORE
Vivli’s AMR Register is featured in an article from Insight, Vivli’s technical partner, titled Leveraging Data, Innovation to Combat the ‘Silent Pandemic’. In the article, ... > MORE
Vivli’s Executive Director, Dr. Rebecca Li, spoke at The Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) Public Meeting on September 13th for the Innovation ... > MORE
Media Roundup: Sci Dev Net: Pharma companies to share data on antimicrobial resistance All Africa: Africa: Pharma Companies to Share Data on Antimicrobial Resistance All ... > MORE
The AMR Register launched on on Tuesday, June 21, 2022 at 10:00ET | 15:00 BST The meeting agenda included: Introduction to the AMR Register Demonstration ... > MORE
Leading biopharmaceutical companies join Vivli’s new global register to accelerate research into antibiotic resistant bacteria Cambridge, MA –The Antimicrobial Resistance Register, unveiled today by the ... > MORE
Join us for a Foundation Briefing on Industry AMR Surveillance: Data for Action. See our inspiring line-up in the agenda and speaker biographies. It ... > MORE
Vivli is pleased to announce that following on from the Wellcome Trust-Open Data Institute (ODI) AMR pilot, Wellcome has awarded a contract to Vivli which ... > MORE